NDC 60505-7053-0 - Buprenorphine and Naloxone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60505-7053
- Requested NDC
- 60505-7053-0
- Package NDCs from labels
- 60505-7053-0, 60505-7053-5
- Manufacturer
- Apotex Corp. | Aveva Drug Delivery Systems, Inc. | Aveva Drug Delivery Systems, Inc
- Effective date
- 2023-07-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Buprenorphine and Naloxone | Apotex Corp. | Aveva Drug Delivery Systems, Inc. | Aveva Drug Delivery Systems, Inc | 2023-07-06 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | Henry Schein, Inc. | ddeebc32-9aab-4a2f-8c87-74335d17d5ef | 2026-11-05 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Henry Schein, Inc. | d39635a4-ddb3-4d32-8211-eb84c78e9f59 | 2026-11-05 | Warnings, Adverse reactions | F850569PQR |
| naloxone hydrochloride | NALOXONE HYDROCHLORIDE | REMEDYREPACK INC. | 5b13a13f-6ec8-41eb-b216-e43ffd68f01e | 2026-11-02 | Warnings, Adverse reactions | F850569PQR |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | PAI Holdings, LLC dba PAI Pharma | 63201a61-6ac5-41ae-8b2d-ff0d3a8ddfd5 | 2026-10-30 | Adverse reactions | 1Q73Q2JULR XF417D3PSL |
| pentazocine and naloxone | PENTAZOCINE AND NALOXONE | Sun Pharmaceutical Industries, Inc. | 41ebdaaf-3bbc-419f-b996-0341efc14623 | 2026-10-29 | Boxed warning, Warnings, Adverse reactions | F850569PQR |
| Buprenorphine hydrochloride | BUPRENORPHINE HYDROCHLORIDE | Gland Pharma Limited | 69ec3405-78ee-4cb4-9180-9bea937a8dcd | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | 56W8MW3EN1 |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Somerset Therapeutics, LLC | b59ee3cc-9604-4abc-81be-897e2f42aa67 | 2026-10-15 | Warnings, Adverse reactions | F850569PQR |
| Rhinoost Smelling Salts | AMMONIA | Guangdong Jiaoyu Biotechnology Co., Ltd | 5d93a397-0528-b09d-e063-6394a90a5439 | 2026-10-11 | Warnings | 5138Q19F1X |
| TEHCIN Smelling Salts | AMMONIA 15% SMELLING SALTS | Foshan Chancheng District Xuntou Electronic Commerce Co., Ltd | 5b6e8a5a-02d0-fc1c-e063-6394a90a1351 | 2026-10-08 | Warnings | 5138Q19F1X |
| OTTFFSS SMELLING SALTS | AMMONIA | Huain Best Trade Co., Ltd. | 5d551a46-b6e0-ea64-e063-6394a90a8999 | 2026-10-08 | Warnings | 5138Q19F1X |
| REXTOVY | NALOXONE HYDROCHLORIDE | International Medication Systems, Ltd. | fe9735db-c57e-44a8-bffb-b87a84c2a6f3 | 2026-09-30 | Warnings, Adverse reactions | F850569PQR |
| ALLBIZ Smelling salts | ALLBIZ SMELLING SALTS | Foshan Chancheng District Xuntou Electronic Commerce Co., Ltd | 5bfc46fe-8414-31ce-e063-6294a90a7852 | 2026-09-21 | Warnings | 5138Q19F1X |
| buprenorphine hydrochloride and naloxone hydrochloride dihydrate | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE | Golden State Medical Supply, Inc. | 4f6e0056-b19d-0d0e-e063-6294a90a16e5 | 2026-09-21 | Warnings, Adverse reactions | 56W8MW3EN1 |
| buprenorphine hydrochloride | BUPRENORPHINE HYDROCHLORIDE | REMEDYREPACK INC. | 9f7b0a28-f937-4d4d-b793-ca3468bd28e0 | 2026-09-17 | Warnings, Adverse reactions | 56W8MW3EN1 |
| BUPRENORPHINE AND NALOXONE | BUPRENORPHINE AND NALOXONE | Major Pharmaceuticals | c5fbec69-e7de-44a8-b9fa-0378ae61a9fe | 2026-09-02 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Amneal Pharmaceuticals LLC | 8091a73d-9ecd-4578-a57b-5d85a2c5a16a | 2026-08-25 | Warnings | F850569PQR |
| Smelling Salts | AMMONIA | Shenzhen Finona Information Technology Co., Ltd | 3874ec89-0f1d-87b9-e063-6394a90a300a | 2026-08-24 | Warnings | 5138Q19F1X |
| Smelling Salts | AMMONIA INHALANT, SMELLING SALTS | Hodayfa Abu Alkian | 524e002c-f509-9395-e063-6394a90acd9e | 2026-08-20 | Warnings | 5138Q19F1X |
| Smelling Salts | AMMONIA INHALANT, SMELLING SALTS | Shenzhen Leadtop E-commerce Co.,Ltd. | 558e8629-6a8d-198d-e063-6294a90ac5fc | 2026-08-19 | Warnings | 5138Q19F1X |
| Smelling Salt | AMMONIA | Shenzhen Jufeng Qisheng Technology Co., Ltd. | 44e1b2c1-f524-782c-e063-6394a90ad1e4 | 2026-08-18 | Warnings | 5138Q19F1X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.